EMR Emerson Electric Company Common Stock

NYSE · Electrical Equipment · Lihat di SEC EDGAR ↗

$138,48

Harga · Jun 8, 2026

Fundamental per Mei 5, 2026

EMR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

Harga

$138.48

Kapitalisasi Pasar

$73.83B

P/E (TTM)

32.5

EPS (TTM)

$4.04

Pendapatan (TTM)

$18.02B

Imbal Hasil Dividen

1.6%

ROE

10.9%

D/E Utang/Ekuitas

0.6

Rentang 52M

$123 – $165

EMR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Pendapatan & Laba Bersih $18.02B

2018-09-30 → 2025-09-30

EPS $4.04

2018-09-30 → 2025-09-30

Arus Kas Bebas $2.67B

2018-09-30 → 2025-09-30

Margin 12.7%

2018-09-30 → 2025-09-30

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik

Tren 5 Tahun

EMR

Median Rekan

P/E (TTM)

32.5

35.7

P/S (TTM)

4.1

P/B

3.6

3.7

Price / FCF (Harga / FCF)

27.7

—

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik

Tren 5 Tahun

EMR

Median Rekan

Gross Margin (Margin Kotor)

52.8%

37.0%

Net Profit Margin (Margin Laba Bersih)

12.7%

12.1%

ROA

5.4%

9.1%

ROE

10.9%

16.2%

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik

Tren 5 Tahun

EMR

Median Rekan

Debt / Equity (Utang / Ekuitas)

0.6

0.0

Current Ratio (Rasio Lancar)

0.9

1.9

Quick Ratio (Rasio Cepat)

0.3

—

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik

Tren 5 Tahun

EMR

Median Rekan

Revenue YoY (Pendapatan YoY)

3.0%

—

Revenue CAGR 3Y (CAGR Pendapatan 3T)

9.3%

—

Revenue CAGR 5Y (CAGR Pendapatan 5T)

1.4%

—

EPS YoY

17.8%

—

Net Income YoY (Laba Bersih YoY)

16.5%

—

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik

Tren 5 Tahun

EMR

Median Rekan

EPS (Diluted)

$4.04

—

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik

Tren 5 Tahun

EMR

Median Rekan

Payout Ratio (Rasio Pembayaran Dividen)

52.0%

—

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

Imbal Hasil Dividen

1.6%

Rasio Pembayaran Dividen

52.0%

CAGR Dividen 5T

—

Tanggal ex-dividen	Jumlah
15 Mei 2026	$0,5550
13 Feb. 2026	$0,5550
14 Nov. 2025	$0,5550
15 Agu 2025	$0,5280
16 Mei 2025	$0,5280
14 Feb. 2025	$0,5280
15 Nov. 2024	$0,5280
16 Agu 2024	$0,5250
16 Mei 2024	$0,5250
15 Feb. 2024	$0,5250
16 Nov. 2023	$0,5250
10 Agu 2023	$0,5200
11 Mei 2023	$0,5200
16 Feb. 2023	$0,5200
9 Nov. 2022	$0,5200
11 Agu 2022	$0,5150
12 Mei 2022	$0,5150
10 Feb. 2022	$0,5150
10 Nov. 2021	$0,5150
12 Agu 2021	$0,5050

EMR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

BELI 34 analis

Beli Kuat 6 17,6%
Beli 16 47,1%
Tahan 11 32,4%
Jual 1 2,9%
Jual Kuat 0 0,0%

Target Harga 12 Bulan

27 analis · 2026-06-02

Median $164.00

Sekarang $138.48

Rendah $104.00

Tinggi $203.00

Target median $164.00 +18,4%

Target rata-rata $163.72 +18,2%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Kejutan Rata-rata

0.01%

Periode	EPS Aktual	EPS Estimasi	Kejutan
31 Maret 2026	$1.54	$1.55	-0.01%
31 Des. 2025	$1.46	$1.43	0.03%
30 Sep. 2025	$1.62	$1.63	-0.01%
30 Juni 2025	$1.52	$1.53	-0.01%
31 Maret 2025	$1.48	$1.43	0.05%

Perbandingan Sejawat Metrik utama vs rekan sektor

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
EMR	$73.83B	32.5	3.0%	12.7%	10.9%	52.8%
VRT	$61.98B	47.5	27.7%	13.0%	37.7%	—
AME	$47.02B	32.1	6.6%	20.0%	14.6%	—
ROK	$39.29B	45.6	0.94%	10.4%	24.3%	48.1%
HUBB	$23.65B	26.9	3.8%	15.2%	24.5%	35.3%
NXT	—	31.4	20.3%	16.5%	27.1%	32.6%
GNRC	—	50.7	-2.0%	3.8%	6.2%	38.3%
VICR	—	42.0	26.1%	26.2%	18.5%	57.3%
RRX	$9.32B	33.4	-1.7%	4.7%	4.3%	37.4%
POWL	$3.68B	20.5	9.1%	16.4%	30.6%	29.4%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Laba Rugi 16

Data Laporan Laba Rugi Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$18.02B	$17.49B	$15.16B	$13.80B	$12.93B	$16.79B	$18.37B	$17.41B	$15.26B	$14.52B	$16.25B	$17.73B
Cost of Revenue	$8.50B	$8.61B	$7.74B	$7.50B	$7.20B	$9.78B	$10.56B	$9.98B	$8.83B	$8.26B	$9.24B	$9.97B
Gross Profit	$9.52B	$8.88B	$7.43B	$6.31B	$7.56B	$7.01B	$7.82B	$7.43B	$6.40B	$6.26B	$7.01B	$10.16B
R&D Expense	$771M	$781M	$523M	$385M	$347M	$439M	$454M	$436M	$340M	$320M	$336M	$356M
SG&A Expense	$5.10B	$5.14B	$4.19B	$3.61B	$3.49B	$3.99B	$4.46B	$4.27B	$3.61B	$3.46B	$3.73B	$4.16B
Interest Expense	·	·	·	·	$147M	·	·	·	·	·	·	·
Interest Income	$150M	$148M	$227M	$34M	$10M	$19M	$27M	$43M	$36M	$27M	$23M	$18M
Other Non-op	$81M	$72M	$145M	$100M	$71M	$12M	$8M	$-61M	$-110M	$-114M	$-98M	$-77M
Pretax Income	$2.93B	$2.02B	$2.90B	$2.43B	$1.76B	$2.33B	$2.86B	$2.67B	$2.33B	$2.32B	$3.81B	$3.19B
Income Tax	$696M	$415M	$642M	$549M	$346M	$345M	$531M	$443M	$660M	$697M	$1.27B	$953M
Net Income	$2.29B	$1.97B	$13.22B	$3.23B	$2.30B	$1.97B	$2.31B	$2.20B	$1.52B	$1.64B	$2.71B	$2.15B
EPS (Basic)	$4.06	$3.44	$23.00	$5.44	$3.85	$3.26	$3.74	$3.48	$2.35	$2.53	$4.01	$3.05
EPS (Diluted)	$4.04	$3.43	$22.88	$5.41	$3.82	$3.24	$3.71	$3.46	$2.35	$2.52	$3.99	$3.03
Shares (Basic)	564,000,000	571,300,000	574,200,000	592,900,000	598,100,000	602,900,000	616,200,000	632,000,000	642,100,000	644,000,000	673,300,000	700,200,000
Shares (Diluted)	566,700,000	574,000,000	577,300,000	596,300,000	601,800,000	606,600,000	620,600,000	635,300,000	643,400,000	646,800,000	676,500,000	704,100,000
EBITDA	$1.52B	$1.69B	$1.05B	$1.04B	$969M	$854M	$822M	$758M	$636M	$568M	$815M	$831M

Neraca 30

Data Neraca Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	·	·	·	·	$2.35B	$3.31B	$1.49B	$1.09B	$3.06B	$3.18B	$3.05B	$3.15B
Short-term Investments	·	·	·	·	·	·	·	·	·	$99M	$99M	·
Receivables	$3.10B	$2.93B	$2.52B	$2.26B	$2.97B	$2.80B	$2.98B	$3.02B	$3.07B	$2.70B	$2.87B	$5.02B
Inventory	$2.21B	$2.18B	$2.01B	$1.74B	$2.05B	$1.93B	$1.88B	$1.81B	$1.70B	$1.21B	$1.26B	$2.06B
Other Current Assets	$1.73B	$1.50B	$1.24B	$1.30B	$1.06B	$761M	$780M	$690M	$422M	$669M	$724M	$642M
Current Assets	$8.58B	$10.19B	$13.82B	$8.51B	$8.43B	$8.81B	$7.14B	$6.62B	$8.25B	$9.96B	$10.05B	$10.87B
PP&E (Net)	$2.87B	$2.81B	$2.36B	$2.24B	$3.74B	$3.69B	$3.64B	$3.56B	$3.32B	$2.93B	$2.93B	$3.80B
PP&E (Gross)	$6.41B	$6.18B	$5.52B	$5.39B	$9.43B	$9.05B	$8.67B	$8.37B	$7.87B	$7.33B	$7.11B	$9.41B
Accum. Depreciation	$3.54B	$3.38B	$3.16B	$3.15B	$5.69B	$5.37B	$5.03B	$4.81B	$4.55B	$4.40B	$4.18B	$5.61B
Goodwill	$18.19B	$18.07B	$14.48B	$13.95B	$6.97B	$6.73B	$6.54B	$6.46B	$5.32B	$3.91B	$3.85B	$4.24B
Intangibles	$9.46B	$10.44B	$6.26B	$6.57B	$2.88B	$2.47B	$2.62B	$2.75B	$1.89B	$902M	$938M	$1.69B
Other Non-current Assets	$2.86B	$2.74B	$2.57B	$2.15B	$1.95B	$1.19B	$565M	$1.00B	$810M	$200M	$239M	$637M
Total Assets	$41.96B	$44.25B	$42.75B	$35.67B	$24.71B	$22.88B	$20.50B	$20.39B	$19.59B	$21.73B	$22.09B	$24.18B
Accounts Payable	$1.38B	$1.33B	$1.27B	$1.28B	$2.11B	$1.72B	$1.87B	$1.94B	$1.78B	$1.52B	$1.54B	$2.95B
Accrued Liabilities	$3.62B	$3.88B	$3.21B	$3.04B	$3.27B	$2.91B	$2.66B	$2.60B	$2.34B	$2.13B	$2.06B	$2.88B
Short-term Debt	$4.19B	$0	$1M	$1.60B	$334M	$838M	$929M	$935M	$592M	$2.32B	$2.26B	$1.94B
Current Liabilities	$9.80B	$5.74B	$5.03B	$7.78B	$6.25B	$5.79B	$5.98B	$6.16B	$5.04B	$8.01B	$7.80B	$8.45B
Capital Leases	$505M	$511M	$404M	$312M	$413M	$373M	$0	·	·	·	·	·
Deferred Tax	·	·	·	·	·	·	$327M	$484M	$425M	$210M	$270M	$572M
Other Non-current Liabilities	$3.55B	$3.84B	$3.51B	$3.15B	·	·	$556M	$656M	$551M	$430M	$1.54B	$2.00B
Long-term Debt	$8.92B	$7.69B	$8.16B	$8.78B	$6.33B	$6.65B	$4.79B	$3.83B	$4.06B	$4.32B	$4.58B	$4.08B
Total Debt	$13.12B	$7.69B	$8.16B	$10.37B	$6.67B	$7.49B	$5.72B	$4.76B	$4.66B	$6.65B	$6.84B	$6.02B
Common Stock	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M
Paid-in Capital	$85M	$169M	$62M	$57M	$522M	$470M	$393M	$348M	$297M	$205M	$170M	$161M
Retained Earnings	$40.60B	$40.83B	$40.07B	$28.05B	$26.05B	$24.95B	$24.20B	$23.07B	$22.00B	$21.72B	$21.31B	$19.87B
Treasury Stock	$20.06B	$18.97B	$18.67B	$16.74B	$16.29B	$15.92B	$15.11B	$13.94B	$13.03B	$12.83B	$12.26B	$9.81B
AOCI	$-821M	$-868M	$-1.25B	$-1.49B	$-872M	$-1.58B	$-1.72B	$-1.01B	$-1.02B	$-2.00B	$-1.62B	$-575M
Stockholders' Equity	$20.28B	$21.64B	$20.69B	$10.36B	$9.88B	$8.40B	$8.23B	$8.95B	$8.72B	$7.57B	$8.08B	$10.12B
Liabilities + Equity	$41.96B	$44.25B	$42.75B	$35.67B	$24.71B	$22.88B	$20.50B	$20.39B	$19.59B	$21.73B	$22.09B	$24.18B
Shares Outstanding	562,800,000	570,200,000	572,000,000	591,400,000	595,800,000	598,000,000	611,000,000	629,200,000	641,700,000	642,796,490	654,608,521	696,605,222

Arus Kas 16

Data Arus Kas Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$1.52B	$1.69B	$1.05B	$842M	$762M	$854M	$822M	$758M	$636M	$568M	$573M	$569M
Stock-based Comp	$263M	$260M	$250M	$125M	$197M	$110M	$120M	$216M	$110M	·	·	·
Amort. of Intangibles	$1.17B	$1.37B	$764M	$530M	$432M	$369M	$359M	$314M	$222M	$177M	$174M	$167M
Restructuring	$136M	$228M	$72M	$75M	$132M	$284M	$95M	$65M	$78M	$96M	$138M	$39M
Other Non-cash	$-985M	$-736M	$-14.07B	$-2.01B	$282M	$302M	$-392M	$-152M	$-82M	$771M	$-1.14B	$828M
Operating Cash Flow	$3.10B	$3.33B	$637M	$2.92B	$3.58B	$3.08B	$3.01B	$2.89B	$1.91B	$2.88B	$2.53B	$3.69B
CapEx	$431M	$419M	$363M	$299M	$404M	$538M	$594M	$617M	$476M	$447M	$588M	$651M
Investing Cash Flow	$-593M	$-5.36B	$12.41B	$-5.33B	$-2.12B	$-740M	$-1.17B	$-2.72B	$1.51B	$-626M	$591M	$-1.16B
Debt Issued	$1.54B	$0	$0	$2.98B	$0	$2.23B	$1.69B	$0	$0	$0	$1.00B	$1M
Net Debt Issued	$1.04B	$-547M	$-741M	$2.45B	$-308M	$1.73B	$1.03B	$-241M	$-254M	$-254M	$496M	$-328M
Stock Repurchased	$1.17B	$435M	$2.00B	$500M	$500M	$942M	$1.25B	$1.00B	$400M	$601M	$2.50B	$1.05B
Net Stock Activity	$-1.17B	$-435M	$-2.00B	$-500M	$-500M	$-942M	$-1.25B	$-1.00B	$-400M	$-601M	$-2.50B	$-1.05B
Dividends Paid	$1.19B	$1.20B	$1.20B	$1.22B	$1.21B	$1.21B	$1.21B	$1.23B	$1.24B	$1.23B	$1.27B	$1.21B
Financing Cash Flow	$-4.51B	$-2.46B	$-6.82B	$2.05B	$-2.42B	$-509M	$-1.39B	$-2.09B	$-3.59B	$-2.04B	$-2.95B	$-2.56B
Net Change in Cash	$-2.04B	$-4.46B	$6.25B	$-550M	$-961M	$1.82B	$401M	$-1.97B	$-120M	$128M	$-95M	$-126M
Free Cash Flow	$2.67B	$2.91B	$274M	$2.39B	$2.99B	$2.54B	$2.41B	$2.27B	$1.44B	$2.43B	$1.84B	$2.92B

Profitabilitas 6

Data Profitabilitas Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	52.8%	50.8%	49.0%	41.7%	41.5%	41.8%	42.5%	42.9%	41.9%	43.1%	40.6%	41.4%
Net Margin	12.7%	11.2%	87.2%	16.5%	12.6%	11.7%	12.6%	12.7%	9.9%	11.3%	12.2%	8.8%
Pretax Margin	16.3%	11.6%	18.0%	20.8%	16.0%	13.9%	15.6%	15.3%	15.3%	16.0%	18.7%	13.6%
EBITDA Margin	8.4%	9.7%	6.9%	5.3%	5.3%	5.1%	4.5%	4.3%	4.2%	3.9%	3.6%	3.4%
ROA	5.4%	4.5%	33.7%	10.7%	9.7%	9.1%	11.3%	11.0%	7.3%	7.5%	11.7%	8.8%
ROE	10.9%	9.3%	85.1%	31.2%	24.0%	24.2%	27.2%	25.4%	18.6%	20.9%	29.8%	20.7%

Likuiditas & Solvabilitas 4

Data Likuiditas & Solvabilitas Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	0.9	1.8	2.7	1.1	1.4	1.5	1.2	1.1	1.6	1.2	1.3	1.3
Quick Ratio	0.3	0.5	0.5	0.4	0.9	1.1	0.7	0.7	1.2	0.7	1.0	1.0
Debt / Equity	0.6	0.4	0.4	1.0	0.7	0.9	0.7	0.5	0.5	0.9	0.8	0.6
LT Debt / Equity	0.4	0.3	0.4	0.8	0.6	0.8	0.5	0.4	0.4	0.5	0.5	0.4

Efisiensi 3

Data Efisiensi Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.4	0.4	0.4	0.7	0.8	0.8	0.9	0.9	0.7	0.7	1.0	1.0
Inventory Turnover	3.9	4.1	4.1	5.4	5.4	5.1	5.7	5.7	6.1	6.7	6.8	7.3
Receivables Turnover	6.0	6.4	6.3	6.6	6.3	5.8	6.1	5.4	5.3	5.2	4.8	5.0

Per Saham 6

Data Per Saham Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$36.04	$37.94	$36.17	$17.52	$16.59	$14.06	$13.47	$14.22	$13.59	$11.77	$12.34	$14.53
Revenue / Share	$31.79	$30.47	$26.27	$32.92	$30.30	$27.67	$29.60	$27.40	$23.72	$22.45	$32.97	$34.85
Cash Flow / Share	$5.47	$5.80	$1.10	$4.90	$5.94	$5.08	$4.84	$4.55	$2.97	$4.45	$3.74	$5.24
Cash / Share	·	·	·	·	$3.95	$5.54	$2.45	$1.74	$4.77	$4.95	$4.67	$4.52
Dividend Paid / Share	$2	$2	$2	$2	$2	$2	$2	$2	$2	$2	$2	$2
EPS (TTM)	$4.04	$3.43	$22.88	$5.41	$3.82	$3.24	$3.71	$3.46	$2.35	$2.52	$3.99	$3.03

Tingkat Pertumbuhan 10

Data Tingkat Pertumbuhan Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	3.0%	15.3%	9.9%	6.7%	-23.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	9.3%	10.6%	-3.3%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	1.4%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	17.8%	-85.0%	322.9%	41.6%	17.9%	·	·	·	·	·	·	·
EPS CAGR 3Y	-9.3%	-3.5%	91.8%	·	·	·	·	·	·	·	·	·
EPS CAGR 5Y	4.5%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	16.5%	-85.1%	309.1%	40.3%	17.2%	·	·	·	·	·	·	·
Net Income CAGR 3Y	-10.8%	-5.1%	88.8%	·	·	·	·	·	·	·	·	·
Net Income CAGR 5Y	3.1%	·	·	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	-0.28%	·	·	·	·	·	·	·	·	·	·	·

Valuasi (TTM) 17

Data Valuasi (TTM) Tahunan untuk EMR
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$18.02B	$17.49B	$15.16B	$13.80B	$12.93B	$16.79B	$18.37B	$17.41B	$15.26B	$14.52B	$16.25B	$17.73B
Net Income TTM	$2.29B	$1.97B	$13.22B	$3.23B	$2.30B	$1.97B	$2.31B	$2.20B	$1.52B	$1.64B	$2.71B	$2.15B
Market Cap	$73.83B	$62.36B	$55.24B	$43.30B	$56.12B	$39.21B	$40.85B	$48.18B	$40.32B	$35.04B	$28.91B	$43.59B
Enterprise Value	·	·	·	·	$60.44B	$43.38B	$45.08B	$51.85B	$41.92B	$38.40B	$32.60B	$46.46B
P/E	32.5	31.9	4.2	13.5	24.7	20.2	18.0	22.1	26.7	21.6	11.1	20.7
P/S	4.1	3.6	3.6	3.1	4.3	2.3	2.2	2.8	2.6	2.4	1.8	2.5
P/B	3.6	2.9	2.7	4.2	5.7	4.7	5.0	5.4	4.6	4.6	3.6	4.3
P / Tangible Book	·	·	·	·	1439.1	·	·	·	·	·	·	·
P / Cash Flow	23.8	18.7	86.7	14.8	15.7	12.7	13.6	16.7	21.1	12.2	11.4	11.8
P / FCF	27.7	21.4	201.6	18.1	18.7	15.4	16.9	21.2	28.1	14.4	15.7	14.9
EV / EBITDA	·	·	·	·	62.4	50.8	54.8	68.4	65.9	67.6	40.0	55.9
EV / FCF	·	·	·	·	20.2	17.0	18.7	22.8	29.2	15.8	17.7	15.9
EV / Revenue	·	·	·	·	4.7	2.6	2.5	3.0	2.7	2.6	2.0	2.6
Dividend Yield	1.6%	1.9%	2.2%	2.8%	2.2%	3.1%	3.0%	2.5%	3.1%	3.5%	4.4%	2.8%
Earnings Yield	3.1%	3.1%	23.7%	7.4%	4.1%	4.9%	5.5%	4.5%	3.7%	4.6%	9.0%	4.8%
Payout Ratio	52.0%	61.0%	9.1%	37.9%	52.5%	61.5%	52.4%	55.8%	81.6%	75.0%	46.8%	56.4%
Annual Payout	$1.19B	$1.20B	$1.20B	$1.22B	$1.21B	$1.21B	$1.21B	$1.23B	$1.24B	$1.23B	$1.27B	$1.21B

Laporan Laba Rugi 14

Data Triwulanan Laporan Laba Rugi untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Revenue	$4.56B	$4.35B	$4.86B	$4.55B	$4.43B	$4.17B	$4.62B	$4.38B	$4.38B	$4.12B	$4.09B	$3.95B	$3.76B	$3.37B	$852M	$3.46B
Cost of Revenue	$2.14B	$2.04B	$2.34B	$2.16B	$2.06B	$1.94B	$2.25B	$2.07B	$2.09B	$2.20B	$2.08B	$1.95B	$1.96B	$1.75B	$2.06B	$1.88B
Gross Profit	·	·	$2.52B	$2.39B	$2.37B	$2.23B	$2.37B	$2.31B	$2.28B	$1.92B	$2.01B	$1.99B	$1.80B	$1.62B	$1.83B	$1.59B
SG&A Expense	$1.32B	$1.24B	$1.33B	$1.27B	$1.28B	$1.22B	$1.31B	$1.25B	$1.30B	$1.28B	$1.11B	$1.04B	$1.00B	$1.03B	$983M	$894M
Interest Income	$26M	$26M	$30M	$31M	$45M	$44M	$43M	$32M	$33M	$40M	$131M	$58M	$18M	$20M	$16M	$11M
Other Non-op	$41M	$24M	$24M	$14M	$17M	$26M	$-25M	$43M	$34M	$20M	$35M	$36M	$30M	$44M	$20M	$29M
Pretax Income	$793M	$775M	$796M	$734M	$629M	$775M	$679M	$455M	$711M	$175M	$1.02B	$822M	$639M	$422M	$603M	$378M
Income Tax	$175M	$169M	$161M	$154M	$199M	$182M	$149M	$88M	$162M	$16M	$242M	$168M	$134M	$98M	$150M	$123M
Net Income	$618M	$605M	$637M	$586M	$485M	$585M	$996M	$329M	$501M	$142M	$744M	$9.35B	$792M	$2.33B	$740M	$921M
EPS (Basic)	·	$1.08	$1.13	$1.04	$0.86	$1.03	$1.74	$0.58	$0.88	$0.25	$1.26	$16.36	$1.39	$3.99	$1.25	$1.55
EPS (Diluted)	·	$1.07	$1.12	$1.04	$0.86	$1.02	$1.73	$0.57	$0.87	$0.25	$1.25	$16.28	$1.38	$3.97	$1.24	$1.54
Shares (Basic)	560,800,000	561,800,000	-1,129,600,000	562,100,000	563,000,000	568,500,000	-1,142,800,000	571,900,000	571,400,000	570,800,000	-1,151,200,000	570,900,000	570,900,000	583,600,000	-1,187,800,000	592,800,000
Shares (Diluted)	563,000,000	564,100,000	-1,134,500,000	564,700,000	565,400,000	571,100,000	-1,148,200,000	574,800,000	574,100,000	573,300,000	-1,157,000,000	574,000,000	573,600,000	586,700,000	-1,194,500,000	596,200,000
EBITDA	$369M	$359M	·	$372M	$384M	$383M	·	$417M	$424M	$422M	·	$257M	$263M	$260M	·	$270M

Neraca 27

Data Triwulanan Neraca untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Receivables	$3.16B	$2.97B	$3.10B	$2.91B	$2.90B	$2.69B	$2.93B	$2.76B	$2.88B	$2.76B	·	$2.49B	$2.33B	$2.23B	·	$2.96B
Inventory	$2.45B	$2.35B	$2.21B	$2.29B	$2.22B	$2.20B	$2.18B	$2.30B	$2.36B	$2.43B	·	$2.08B	$2.03B	$2.00B	·	$2.32B
Other Current Assets	$1.85B	$1.77B	$1.73B	$1.66B	$1.62B	$1.47B	$1.50B	$1.46B	$1.46B	$1.40B	·	$1.23B	$1.23B	$1.29B	·	$1.57B
Current Assets	$9.25B	$8.84B	$8.58B	$9.07B	$8.63B	$9.19B	$10.19B	$8.82B	$9.01B	$8.67B	·	$15.76B	$8.98B	$9.00B	·	$9.38B
PP&E (Net)	$2.85B	$2.87B	$2.87B	$2.79B	$2.76B	$2.74B	$2.81B	$2.69B	$2.69B	$2.70B	·	$2.27B	$2.26B	$2.26B	·	$3.36B
PP&E (Gross)	$6.47B	$6.46B	$6.41B	$6.27B	$6.16B	$6.07B	$6.18B	$5.99B	$5.98B	$5.95B	·	$5.49B	$5.45B	$5.37B	·	$8.82B
Accum. Depreciation	$3.62B	$3.59B	$3.54B	$3.48B	$3.40B	$3.32B	$3.38B	$3.31B	$3.29B	$3.25B	·	$3.22B	$3.18B	$3.11B	·	$5.46B
Goodwill	$18.15B	$18.18B	$18.19B	$18.16B	$18.00B	$17.91B	$18.07B	$17.94B	$17.96B	$17.98B	$14.48B	$14.13B	$14.10B	$14.09B	$13.95B	$14.75B
Intangibles	$8.95B	$9.21B	$9.46B	$9.67B	$9.82B	$10.03B	$10.44B	$10.63B	$10.98B	$11.27B	·	$6.15B	$6.30B	$6.46B	·	$6.93B
Other Non-current Assets	$2.88B	$2.84B	$2.86B	$2.83B	$2.77B	$2.74B	$2.74B	$2.61B	$2.61B	$2.64B	·	$2.51B	$2.27B	$2.27B	·	$2.63B
Total Assets	$42.09B	$41.94B	$41.96B	$42.52B	$41.98B	$42.61B	$44.25B	$45.59B	$46.44B	$46.51B	$42.75B	$44.17B	$36.15B	$36.24B	$35.67B	$37.04B
Accounts Payable	$1.47B	$1.34B	$1.38B	$1.27B	$1.34B	$1.26B	$1.33B	$1.25B	$1.27B	$1.23B	·	$1.22B	$1.21B	$1.22B	·	$2.04B
Accrued Liabilities	$3.38B	$3.35B	$3.62B	$3.51B	$3.32B	$3.63B	$3.88B	$3.35B	$3.24B	$3.30B	·	$4.73B	$3.25B	$3.95B	·	$3.54B
Short-term Debt	·	·	$4.19B	·	·	·	$0	·	·	·	·	·	·	·	·	·
Current Liabilities	$10.65B	$10.52B	$9.80B	$10.73B	$10.85B	$5.96B	$5.74B	$7.59B	$7.66B	$7.76B	·	$6.61B	$7.55B	$8.16B	·	$8.81B
Capital Leases	$554M	$513M	$505M	$488M	$488M	$489M	$511M	$511M	$511M	$465M	·	$360M	$305M	$306M	·	$384M
Other Non-current Liabilities	$3.56B	$3.55B	$3.55B	$3.62B	$3.69B	$3.72B	$3.84B	$4.19B	$4.38B	$4.56B	·	$3.50B	$2.93B	$3.06B	·	·
Long-term Debt	·	·	$8.92B	·	·	·	$7.69B	·	·	·	·	·	·	·	·	·
Total Debt	$7.55B	$7.58B	·	$8.28B	$8.18B	$6.56B	·	$7.11B	$7.61B	$7.63B	·	$7.64B	$8.17B	$8.16B	·	$8.37B
Common Stock	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M	$477M	·	$477M	$477M	$477M	·	$477M
Paid-in Capital	$64M	$16M	$85M	$28M	$0	$113M	$169M	$140M	$158M	$140M	·	$112M	$138M	$112M	·	$42M
Retained Earnings	$41.18B	$40.87B	$40.60B	$40.27B	$39.98B	$41.11B	$40.83B	$40.13B	$40.11B	$39.91B	·	$39.62B	$30.57B	$30.08B	·	$27.62B
Treasury Stock	$20.55B	$20.26B	$20.06B	$20.05B	$20.05B	$19.87B	$18.97B	$18.72B	$18.75B	$18.76B	·	$18.68B	$18.68B	$18.68B	·	$16.67B
AOCI	$-861M	$-828M	$-821M	$-850M	$-1.15B	$-1.34B	$-868M	$-1.24B	$-1.10B	$-1.09B	·	$-1.07B	$-1.15B	$-1.25B	$-1.49B	$-1.15B
Stockholders' Equity	$20.30B	$20.28B	$20.28B	$19.87B	$19.25B	$20.49B	$21.64B	$20.80B	$20.90B	$20.67B	·	$20.46B	$11.36B	$10.73B	·	$10.31B
Liabilities + Equity	$42.09B	$41.94B	$41.96B	$42.52B	$41.98B	$42.61B	$44.25B	$45.59B	$46.44B	$46.51B	·	$44.17B	$36.15B	$36.24B	·	$37.04B
Shares Outstanding	560,100,000	562,000,000	562,800,000	562,800,000	562,500,000	563,900,000	570,200,000	572,700,000	572,100,000	571,700,000	·	571,500,000	571,500,000	571,400,000	·	592,200,000

Arus Kas 15

Data Triwulanan Arus Kas untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
D&A	$369M	$359M	$379M	$372M	$384M	$383M	$426M	$417M	$424M	$422M	$271M	$257M	$263M	$260M	$271M	$222M
Stock-based Comp	$58M	$55M	$65M	$71M	$59M	$68M	$57M	$56M	$73M	$74M	$52M	$56M	$40M	$102M	$34M	$0
Restructuring	$45M	$9M	$67M	$37M	$21M	$11M	$58M	$57M	$30M	$83M	$31M	$12M	$19M	$10M	$31M	$29M
Other Non-cash	·	$-677M	·	·	·	$-413M	·	·	·	$-470M	·	·	·	$-2.56B	·	·
Operating Cash Flow	$779M	$699M	$1.01B	$1.07B	$241M	$777M	$1.08B	$1.09B	$743M	$415M	$-643M	$794M	$68M	$418M	$1.22B	$740M
CapEx	$85M	$97M	$168M	$93M	$87M	$83M	$168M	$92M	$82M	$77M	$169M	$73M	$62M	$59M	$100M	$-26M
Investing Cash Flow	$-81M	$-125M	$-200M	$-129M	$-122M	$-142M	$3.20B	$-75M	$-37M	$-8.45B	$-685M	$10.37B	$-152M	$2.89B	$-359M	$-5.13B
Debt Issued	·	·	$0	$0	·	·	$0	$0	·	·	$0	$0	$0	$0	$0	$0
Net Debt Issued	·	$-587M	·	·	·	$-2M	·	·	·	$0	·	·	·	$-9M	·	·
Stock Repurchased	$292M	$250M	$20M	$25M	$223M	$899M	$260M	$0	$0	$175M	$0	$0	$0	$2.00B	$82M	$133M
Net Stock Activity	·	$-250M	·	·	·	$-899M	·	·	·	$-175M	·	·	·	$-2.00B	·	·
Dividends Paid	$312M	$312M	$297M	$297M	$297M	$301M	$300M	$301M	$300M	$300M	$298M	$297M	$297M	$306M	$305M	$305M
Financing Cash Flow	$-649M	$-364M	$-1.49B	$-637M	$-1.09B	$-1.29B	$-3.04B	$-1.03B	$-442M	$2.06B	$-521M	$-3.27B	$-141M	$-2.90B	$-1.51B	$58M
Net Change in Cash	$43M	$204M	$-675M	$332M	$-947M	$-754M	$1.29B	$-20M	$242M	$-5.97B	$-1.91B	$7.91B	$-225M	$467M	$-725M	$-4.40B
Free Cash Flow	·	$602M	·	·	·	$694M	·	·	·	$338M	·	·	·	$359M	·	·

Profitabilitas 5

Data Triwulanan Profitabilitas untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Net Margin	13.6%	13.9%	·	12.9%	10.9%	14.0%	·	7.5%	11.5%	3.5%	·	·	·	69.1%	·	18.4%
Pretax Margin	17.4%	17.8%	·	16.1%	14.2%	18.6%	·	10.4%	14.9%	3.4%	·	·	·	12.5%	·	23.9%
EBITDA Margin	8.1%	8.3%	·	8.2%	8.7%	9.2%	·	9.5%	9.7%	10.2%	·	·	·	7.7%	·	5.4%
ROA	1.5%	1.4%	·	1.3%	1.1%	1.3%	·	0.73%	1.2%	0.34%	·	23.0%	2.4%	7.4%	·	3.0%
ROE	3.1%	3.0%	·	2.9%	2.4%	2.8%	·	1.6%	3.1%	0.90%	·	60.8%	7.2%	22.2%	·	9.4%

Likuiditas & Solvabilitas 4

Data Triwulanan Likuiditas & Solvabilitas untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Current Ratio	0.9	0.8	·	0.8	0.8	1.5	·	1.2	1.2	1.1	·	2.4	1.2	1.1	·	1.1
Quick Ratio	0.3	0.3	·	0.3	0.3	0.5	·	0.4	0.4	0.4	·	0.4	0.3	0.3	·	0.3
Debt / Equity	0.4	0.4	·	0.4	0.4	0.3	·	0.3	0.4	0.4	·	0.4	0.7	0.8	·	0.8
LT Debt / Equity	0.4	0.4	·	0.4	0.4	0.3	·	0.3	0.4	0.4	·	0.4	0.7	0.8	·	0.8

Efisiensi 3

Data Triwulanan Efisiensi untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	·	·	0.1	·	0.2
Inventory Turnover	0.9	0.9	·	0.9	0.9	0.8	·	0.9	1.0	1.0	·	0.9	0.9	0.8	·	1.3
Receivables Turnover	1.5	1.5	·	1.6	1.5	1.5	·	1.7	1.7	1.7	·	·	·	1.4	·	1.8

Per Saham 5

Data Triwulanan Per Saham untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Book Value / Share	$36.25	$36.08	·	$35.31	$34.22	$36.34	·	$36.32	$36.53	$36.16	·	$35.81	$19.88	$18.77	·	$17.42
Revenue / Share	$8.10	$7.70	·	$8.06	$7.84	$7.31	·	$7.62	$7.62	$7.18	·	·	·	$5.75	·	$8.39
Cash Flow / Share	·	$1.24	·	·	·	$1.36	·	·	·	$0.72	·	·	·	$0.71	·	·
Dividend Paid / Share	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1
EPS (TTM)	$4.09	$4.09	·	$4.65	$4.18	$4.19	·	$2.98	$18.69	$19.20	·	$22.87	$8.13	$7.88	·	$5.28

Valuasi (TTM) 11

Data Triwulanan Valuasi (TTM) untuk EMR
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Revenue TTM	$18.32B	$18.19B	·	$17.78B	$17.61B	$17.55B	·	$16.96B	$16.53B	$15.91B	·	$14.97B	$14.49B	$1.66B	·	$14.86B
Net Income TTM	$2.45B	$2.31B	·	$2.65B	$2.40B	$2.41B	·	$1.72B	$10.74B	$11.03B	·	$13.21B	$4.78B	$4.67B	·	$3.16B
Market Cap	$73.38B	$74.59B	·	$75.04B	$61.67B	$69.88B	·	$63.09B	$64.89B	$55.64B	·	$51.66B	$49.80B	$54.89B	·	$47.10B
P/E	32.0	32.4	·	28.7	26.2	29.6	·	37.0	6.1	5.1	·	4.0	10.7	12.2	·	15.1
P/S	4.0	4.1	·	4.2	3.5	4.0	·	3.7	3.9	3.5	·	3.5	3.4	33.1	·	3.2
P/B	3.6	3.7	·	3.8	3.2	3.4	·	3.0	3.1	2.7	·	2.5	4.4	5.1	·	4.6
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	277.7	·	·	·	·
P / Cash Flow	·	106.7	·	·	·	89.9	·	·	·	134.1	·	·	·	131.3	·	·
P / FCF	·	123.9	·	·	·	100.7	·	·	·	164.6	·	·	·	152.9	·	·
Earnings Yield	3.1%	3.1%	·	3.5%	3.8%	3.4%	·	2.7%	16.5%	19.7%	·	25.3%	9.3%	8.2%	·	6.6%
Payout Ratio	·	51.6%	·	·	·	51.4%	·	·	·	211.3%	·	·	·	13.1%	·	·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Laporan Laba Rugi

	2025-09-30	2024-12-31	2024-09-30	2023-09-30	2022-12-31
Pendapatan	$18.02B	—	$17.49B	$15.16B	$1.66B
Margin Kotor %	52.8%	—	50.8%	49.0%	—
Laba Bersih	$2.29B	—	$1.97B	$13.22B	—
EPS Dilusian	$4.04	—	$3.43	$22.88	—

Neraca

	2025-09-30	2024-12-31	2024-09-30	2023-09-30	2022-12-31
Utang / Ekuitas	0.6	—	0.4	0.4	—
Rasio Lancar	0.9	—	1.8	2.7	—
Rasio Cepat	0.3	—	0.5	0.5	—

Arus Kas

	2025-09-30	2024-12-31	2024-09-30	2023-09-30	2022-12-31
Arus Kas Bebas	$2.67B	—	$2.91B	$274M	—

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

Emerson Electric Co. (EMR) Partners with SiMa.ai to Pursue $153.9 Billion Industrial AI Opportunities Yahoo Finance · 3 jam, 58 menit lalu
Laporan Analis: Emerson Electric Co Yahoo Finance · 1 bulan lalu
3 Saham Dividen Industri yang Tetap Membayar Apa Pun yang Terjadi di Pasar Nasdaq · 1 bulan lalu
Yancoal menandatangani kesepakatan $2,4 miliar untuk 80% saham di Tambang Kestrel Coal Yahoo Finance · 1 bulan, 3 minggu lalu
Wells Fargo Memangkas Target Harga Emerson (EMR), Menyoroti Hambatan Makro yang Familiar Yahoo Finance · 1 bulan, 3 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

📊

Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

EMR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

EMR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Rata-rata bergerak dan lapisan tumpang tindih

Volume

Osilator

Momentum dan tren

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

EMR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

Target Harga 12 Bulan

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Perbandingan Sejawat Metrik utama vs rekan sektor

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap